GELS logo

Gelteq Limited Ordinary Shares

GELS
Healthcare|Drug Manufacturers - Specialty & Generic|AU
$0.44
-0.02 (-3.42%)
Cash / Share
$0.00

About

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

Stock Price

-58.9%(1Y)
1M
-19.8%
3M
-21.1%
6M
-6.4%
YTD
-45.0%
1Y
-56.9%
3Y
-85.0%
5Y
-85.0%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$4.0M
Employees7
CEONathan Jacob Givoni
IPO DateOct 29, 2024
Beta-0.36
52-Week Range$0.387 – $2.01
Avg Volume2,769,907
ExchangeNASDAQ
Websitegelteq.com

Ownership

Float39.6%
Shares Outstanding9.2M

Recent Insider Trades

WYNNE Paul MichaelOTHER
Mar 18, 20260 shares
Szewach Simon HOTHER
Mar 18, 20260 shares
Szewach Simon HOTHER
Jul 1, 202665,000 shares @ $2.00
Karp Bradley GlennOTHER
Mar 18, 20260 shares
Givoni Nathan JOTHER
Mar 18, 20260 shares

Peers

AYTUAytu BioPharma, Inc.
$19.9M
BFRGBullfrog AI Holdings, Inc. Common Stock
$9.6M
BFRIBiofrontera Inc.
$12.3M
BGLCBioNexus Gene Lab Corp.
$2.0M
COCPCocrystal Pharma, Inc.
$20.0M
EVGNEvogene Ltd.
$2.3M
IMNNImunon, Inc.
$4.7M
IMRNImmuron Limited
$5.4M
Data last updated: Nov 9, 2026, 04:11 AM